DE60043229D1 - Zusammensetzung zur gefässbeschichtung - Google Patents

Zusammensetzung zur gefässbeschichtung

Info

Publication number
DE60043229D1
DE60043229D1 DE60043229T DE60043229T DE60043229D1 DE 60043229 D1 DE60043229 D1 DE 60043229D1 DE 60043229 T DE60043229 T DE 60043229T DE 60043229 T DE60043229 T DE 60043229T DE 60043229 D1 DE60043229 D1 DE 60043229D1
Authority
DE
Germany
Prior art keywords
composition
vessel coating
coating
vessel
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60043229T
Other languages
English (en)
Inventor
Jeremy Ollerenshaw
Uemit Yueksel
Kirby S Black
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Artivion Inc
Original Assignee
Cryolife Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryolife Inc filed Critical Cryolife Inc
Application granted granted Critical
Publication of DE60043229D1 publication Critical patent/DE60043229D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/92—Method or apparatus for preparing or treating prosthetic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/92—Method or apparatus for preparing or treating prosthetic
    • Y10S623/921—Blood vessel
DE60043229T 1999-09-15 2000-09-15 Zusammensetzung zur gefässbeschichtung Expired - Lifetime DE60043229D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15395099P 1999-09-15 1999-09-15
PCT/US2000/025310 WO2001019347A1 (en) 1999-09-15 2000-09-15 Vascular coating composition

Publications (1)

Publication Number Publication Date
DE60043229D1 true DE60043229D1 (de) 2009-12-10

Family

ID=22549391

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60043229T Expired - Lifetime DE60043229D1 (de) 1999-09-15 2000-09-15 Zusammensetzung zur gefässbeschichtung

Country Status (10)

Country Link
US (2) US6372229B1 (de)
EP (1) EP1214057B1 (de)
JP (1) JP2003509362A (de)
AT (1) ATE446776T1 (de)
AU (1) AU769136B2 (de)
CA (1) CA2385150C (de)
DE (1) DE60043229D1 (de)
HK (1) HK1047404B (de)
NO (1) NO20021281L (de)
WO (1) WO2001019347A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60043229D1 (de) * 1999-09-15 2009-12-10 Cryolife Inc Zusammensetzung zur gefässbeschichtung
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
US8349348B2 (en) * 2002-08-06 2013-01-08 Matrix Medical, Llc Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
US9101536B2 (en) * 2002-08-06 2015-08-11 Matrix Medical Llc Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
US10098981B2 (en) 2002-08-06 2018-10-16 Baxter International Inc. Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
JP4966494B2 (ja) 2002-08-06 2012-07-04 マトリックス メディカル エルエルシー 生体適合性相転化可能なタンパク性組成物ならびにその製造および使用方法
DE10236152A1 (de) * 2002-08-07 2004-02-19 Marker Deutschland Gmbh Ski- und Skibindungs-Kombination
US7803150B2 (en) * 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
WO2005122870A2 (en) 2004-06-14 2005-12-29 Pneumrx, Inc. Lung access device
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
US20050281799A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting damaged lung tissue using compositions
US7549984B2 (en) * 2004-06-16 2009-06-23 Pneumrx, Inc. Method of compressing a portion of a lung
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
WO2006014567A2 (en) * 2004-07-08 2006-02-09 Pneumrx, Inc. Pleural effusion treatment device, method and material
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US9125639B2 (en) 2004-11-23 2015-09-08 Pneumrx, Inc. Steerable device for accessing a target site and methods
US20070014830A1 (en) * 2005-06-08 2007-01-18 Tijsma Edze J Drug-releasing sinus stent
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7993675B2 (en) * 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
AU2007294808A1 (en) * 2006-09-13 2008-03-20 Southeastern Medical Technologies, Llc Methods and compositions for sealing and adhering biological tissues and medical uses thereof
WO2008036763A2 (en) * 2006-09-20 2008-03-27 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US20090011043A1 (en) * 2007-07-03 2009-01-08 Hua Xie Tissue sealant made from whole blood
DK2219555T3 (en) 2007-12-03 2015-08-24 Tenaxis Medical Inc Biocompatible phase invertible proteinaceous compositions
EP2303254B1 (de) 2008-06-12 2019-10-30 Medtronic Xomed, Inc. Produkt zur behandlung von chronischen wunden mit einem extrazellulären polymer-substanz-solvatisierungssystem
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US9155815B2 (en) 2009-04-17 2015-10-13 Tenaxis Medical, Inc. Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
EP2432422A4 (de) 2009-05-18 2018-01-17 PneumRx, Inc. Querschnittsmodifikation während des einsatzes einer verlängerten vorrichtung zur reduzierung des lungenvolumens
WO2011040969A1 (en) * 2009-09-30 2011-04-07 Massachusetts Institute Of Technology Compositions and methods for the treatment of atherosclerosis and other related diseases
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
WO2019231763A1 (en) 2018-05-27 2019-12-05 Christos Angeletakis Tissue adhesives and sealants using naturally derived aldehydes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247406A (en) 1979-04-23 1981-01-27 Widder Kenneth J Intravascularly-administrable, magnetically-localizable biodegradable carrier
US4979959A (en) 1986-10-17 1990-12-25 Bio-Metric Systems, Inc. Biocompatible coating for solid surfaces
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
DE68922497T2 (de) * 1988-08-24 1995-09-14 Marvin J Slepian Endoluminale dichtung mit bisdegradierbaren polymeren.
US5213580A (en) * 1988-08-24 1993-05-25 Endoluminal Therapeutics, Inc. Biodegradable polymeric endoluminal sealing process
US5654267A (en) 1988-12-20 1997-08-05 La Jolla Cancer Research Center Cooperative combinations of ligands contained within a matrix
CA2070149A1 (en) * 1991-06-04 1992-12-05 Stephen J. Boccuzzi Hmg-coa reductase inhibitors in the prevention of restenosis following coronary angloplasty
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method
US5914345A (en) * 1994-10-11 1999-06-22 Endoluminal Therapeutics, Inc. Treatment of tissues to reduce subsequent response to injury
US5900245A (en) * 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
DE60043229D1 (de) * 1999-09-15 2009-12-10 Cryolife Inc Zusammensetzung zur gefässbeschichtung

Also Published As

Publication number Publication date
NO20021281D0 (no) 2002-03-14
CA2385150C (en) 2010-11-23
HK1047404A1 (en) 2003-02-21
EP1214057A1 (de) 2002-06-19
JP2003509362A (ja) 2003-03-11
HK1047404B (zh) 2010-05-20
US20020183244A1 (en) 2002-12-05
ATE446776T1 (de) 2009-11-15
EP1214057B1 (de) 2009-10-28
US6849262B2 (en) 2005-02-01
EP1214057A4 (de) 2006-03-29
NO20021281L (no) 2002-03-26
AU769136B2 (en) 2004-01-15
WO2001019347A1 (en) 2001-03-22
AU7381100A (en) 2001-04-17
CA2385150A1 (en) 2001-03-22
US6372229B1 (en) 2002-04-16

Similar Documents

Publication Publication Date Title
DE60043229D1 (de) Zusammensetzung zur gefässbeschichtung
ATE382681T1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
WO2001088103A3 (en) Compositions and methods for tissue dedifferentiation and regeneration
ATE305788T1 (de) (s,s)-reboxetin zur behandlung von inkontinenz
ATE543509T1 (de) Material und verfahren zur förderung der reparatur von nervengewebe
WO2003080801A3 (en) Adipose stromal stem cells for tissue and vascular modification
UY26205A1 (es) Derivados de indoloxoacetil piperazina antiviricos
WO2003087303A3 (en) Tissue composites and uses thereof
ATE404228T1 (de) Implantat mit einer keramischen beschichtung
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
ATE448811T1 (de) Verfahren zur verbesserung der anhaftung von weichteilgewebe und implantate, die gebrauch von diesem verfahen machen
ATE296123T1 (de) Verfahren zur herstellung bioaktiver implantatoberflächen
TR199802441A3 (tr) Kanda asiri ürik asit bulunmasinin tedavisi ve önlenmesi için yöntem ve terkip.
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE69937679D1 (de) Wasserlösliche zusammensetzung enthaltend aktive inhaltsstoffe zur depigmentierung der haut
DE60002003D1 (de) Verfahren zur Herstellung von Silikon-Polyether-Copolymeren mit vermindertem Geruch
MY145184A (en) Hydrophobic tooth whitening system and methods of use
BR0014560B1 (pt) uso de uma composiÇço de tratamento de tecidos.
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
NO20001799L (no) FremgangsmÕte for rensing av kirurgiske instrumenter
AU2001272622A1 (en) Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair
DE69901243T2 (de) Artikulator zur herstellung von zahnärztlichen prothesen
DE60105053D1 (de) Zusammensetzungen zur behandlung von gewebe
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
ATE222501T1 (de) Tissue-faktor zur beeinflussung von gefässbildung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition